RAGE signaling sustains inflammation and promotes tumor development.

The Journal of Experimental Medicine
Christoffer GebhardtPeter Angel

Abstract

A broad range of experimental and clinical evidence has highlighted the central role of chronic inflammation in promoting tumor development. However, the molecular mechanisms converting a transient inflammatory tissue reaction into a tumor-promoting microenvironment remain largely elusive. We show that mice deficient for the receptor for advanced glycation end-products (RAGE) are resistant to DMBA/TPA-induced skin carcinogenesis and exhibit a severe defect in sustaining inflammation during the promotion phase. Accordingly, RAGE is required for TPA-induced up-regulation of proinflammatory mediators, maintenance of immune cell infiltration, and epidermal hyperplasia. RAGE-dependent up-regulation of its potential ligands S100a8 and S100a9 supports the existence of an S100/RAGE-driven feed-forward loop in chronic inflammation and tumor promotion. Finally, bone marrow chimera experiments revealed that RAGE expression on immune cells, but not keratinocytes or endothelial cells, is essential for TPA-induced dermal infiltration and epidermal hyperplasia. We show that RAGE signaling drives the strength and maintenance of an inflammatory reaction during tumor promotion and provide direct genetic evidence for a novel role for RAGE in link...Continue Reading

References

Jan 1, 1992·Pharmacology & Therapeutics·J DiGiovanni
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
May 16, 2001·Genesis : the Journal of Genetics and Development·R ConstienB Arnold
Oct 3, 2001·The Journal of Clinical Investigation·A M SchmidtD M Stern
Sep 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Karin Muller-DeckerGerhard Furstenberger
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Jan 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joanne M LumsdenRichard J Hodes
Jul 3, 2003·The Journal of Biological Chemistry·Narkunaraja ShanmugamRama Natarajan
Dec 12, 2003·Nature Reviews. Cancer·Robert Eferl, Erwin F Wagner
Jun 3, 2004·The Journal of Clinical Investigation·Birgit LiliensiekBernd Arnold
Mar 8, 2005·Nature Immunology·Thomas JamiesonGerard J Graham
Mar 16, 2005·Cancer Cell·Frances BalkwillAlberto Mantovani
Jun 24, 2005·The American Journal of Pathology·Christoffer GebhardtJochen Hess
Sep 1, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Angelika BierhausPeter P Nawroth
Sep 22, 2005·Nature Reviews. Immunology·Michael Karin, Florian R Greten
Jan 7, 2006·Nature Reviews. Cancer·Karin E de VisserLisa M Coussens
Feb 18, 2006·Klinische Monatsblätter für Augenheilkunde·J von EickenH Höh
Mar 15, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Eli Pikarsky, Yinon Ben-Neriah
Jul 19, 2006·Biochemical Pharmacology·Christoffer GebhardtJochen Hess
Sep 28, 2006·The American Journal of Pathology·Martin AndrassyAngelika Bierhaus
Oct 7, 2006·Journal of Leukocyte Biology·Roberta BianchiRosario Donato
Feb 3, 2007·The EMBO Journal·Valeria V OrlovaTriantafyllos Chavakis
Mar 29, 2007·Cancer Research·Jennifer M Thomas-AhnerTatiana M Oberyszyn
Jul 4, 2007·The Journal of Clinical Investigation·Robert J B NibbsGerard J Graham

❮ Previous
Next ❯

Citations

Mar 31, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Paweł Piątkiewicz, Anna Czech
Aug 13, 2010·Basic Research in Cardiology·H Christian VolzMartin Andrassy
Aug 15, 2013·Archives of Dermatological Research·Kelly E JohnsonTraci A Wilgus
Apr 30, 2008·Amino Acids·Jens Pietzsch, Susan Hoppmann
Jan 24, 2013·Cell Biochemistry and Biophysics·Xuejie ZhuXueqiong Zhu
Dec 15, 2010·Oncogene·D TangH J Zeh
Oct 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Alexander J MullerAndrew L Mellor
Apr 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Rui KangHerbert J Zeh
Oct 24, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stefan K DrexlerAmir S Yazdi
Feb 13, 2008·The Journal of Experimental Medicine·Michael Dougan, Glenn Dranoff
Dec 24, 2009·Carcinogenesis·Armando RojasErik Morales
Jul 9, 2008·Current Opinion in Lipidology·Nahla YounisPaul N Durrington
Apr 19, 2011·Genes & Development·Katrin TschöpNicholas Dyson
Dec 15, 2010·Science Translational Medicine·Ronald WolfStuart H Yuspa
Nov 15, 2008·Annual Review of Immunology·Michael Dougan, Glenn Dranoff
Apr 9, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Diana M Lim, Mei-Lun Wang
Jun 24, 2010·Cancer Research·Anastasia Z KaleaBarry I Hudson
Apr 30, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Li JiaoRachael Z Stolzenberg-Solomon
Jan 14, 2011·Molecular Cancer Research : MCR·Mie IchikawaGeetha Srikrishna
Sep 14, 2011·Journal of Innate Immunity·Geetha Srikrishna
Sep 8, 2012·American Journal of Respiratory and Critical Care Medicine·Po-Hao FengHan-Pin Kuo
Dec 7, 2010·American Journal of Respiratory Cell and Molecular Biology·Paul R ReynoldsJohn R Hoidal
May 12, 2009·Cell Communication and Signaling : CCS·Astrid RiehlJochen Hess
Mar 19, 2009·Journal of Translational Medicine·Louis J SparveroMichael T Lotze
Jan 19, 2012·Journal of Neuroinflammation·Colleen S Curran, Paul J Bertics

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
FACS
electrophoresis
confocal microscopy

Software Mentioned

Leica
Photoshop CS
LAS AF
Adobe

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Biochemical Pharmacology
Christoffer GebhardtJochen Hess
Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Angelika BierhausPeter P Nawroth
© 2021 Meta ULC. All rights reserved